141 related articles for article (PubMed ID: 32949235)
41. The Status of Epstein-Barr Virus Infection in Intestinal Mucosa of Chinese Patients with Inflammatory Bowel Disease.
Li X; Chen N; You P; Peng T; Chen G; Wang J; Li J; Liu Y
Digestion; 2019; 99(2):126-132. PubMed ID: 30235444
[TBL] [Abstract][Full Text] [Related]
42. News from the "5th International Meeting on Inflammatory Bowel Diseases" CAPRI 2010.
Latella G; Fiocchi C; Caprili R
J Crohns Colitis; 2010 Dec; 4(6):690-702. PubMed ID: 21122584
[TBL] [Abstract][Full Text] [Related]
43. Risks of serious infection or lymphoma with anti-tumor necrosis factor therapy for pediatric inflammatory bowel disease: a systematic review.
Dulai PS; Thompson KD; Blunt HB; Dubinsky MC; Siegel CA
Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1443-51; quiz e88-9. PubMed ID: 24462626
[TBL] [Abstract][Full Text] [Related]
44. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
Economopoulos T; Papageorgiou S; Dimopoulos MA; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
Acta Haematol; 2005; 113(2):97-103. PubMed ID: 15802887
[TBL] [Abstract][Full Text] [Related]
45. Impact of treatment variability and clinicopathological characteristics on survival in patients with Epstein-Barr-Virus positive diffuse large B cell lymphoma.
Witte HM; Merz H; Biersack H; Bernard V; Riecke A; Gebauer J; Lehnert H; von Bubnoff N; Feller AC; Gebauer N
Br J Haematol; 2020 Apr; 189(2):257-268. PubMed ID: 31958882
[TBL] [Abstract][Full Text] [Related]
46. Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Involving the Colon in a Patient With Ulcerative Pancolitis and Polymyositis on Long-Term Methotrexate Therapy.
Chang MD; Markham MJ; Liu X
Gastroenterology Res; 2016 Oct; 9(4-5):83-86. PubMed ID: 27785332
[TBL] [Abstract][Full Text] [Related]
47. [Clinical Characteristics of 219 Patients with Primary Gastrointestinal Non-Hodgkin's Lymphoma].
Li YY; Hu DZ; Wang YF; Zhao ZG; Cao Z; Zhang YZ; Zhang HL; Tian C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):849-854. PubMed ID: 32552946
[TBL] [Abstract][Full Text] [Related]
48. [Epstein-Barr virus-related lymphomas in patients with inflammatory bowel disease].
Juffermans NP; Jager A; Kersten MJ; van Oers MH; Hommes DW
Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1859-63. PubMed ID: 16128185
[TBL] [Abstract][Full Text] [Related]
49. Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders.
Crombie JL; LaCasce AS
Front Oncol; 2019; 9():109. PubMed ID: 30899698
[TBL] [Abstract][Full Text] [Related]
50. Two rare cases of Epstein-Barr virus-associated lymphoproliferative disorders in inflammatory bowel disease patients on thiopurines and other immunosuppressive medications.
Subramaniam K; Cherian M; Jain S; Latimer M; Corbett M; D'Rozario J; Pavli P
Intern Med J; 2013 Dec; 43(12):1339-42. PubMed ID: 24330365
[TBL] [Abstract][Full Text] [Related]
51. Anatomic distribution, clinical features, and survival data of 87 cases primary gastrointestinal lymphoma.
Ge Z; Liu Z; Hu X
World J Surg Oncol; 2016 Mar; 14():85. PubMed ID: 26988370
[TBL] [Abstract][Full Text] [Related]
52. Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
Hong JY; Ryu KJ; Park C; Hong M; Ko YH; Kim WS; Kim SJ
Oncotarget; 2017 Feb; 8(8):13782-13791. PubMed ID: 28099151
[TBL] [Abstract][Full Text] [Related]
53. Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low.
Farrell RJ; Ang Y; Kileen P; O'Briain DS; Kelleher D; Keeling PW; Weir DG
Gut; 2000 Oct; 47(4):514-9. PubMed ID: 10986211
[TBL] [Abstract][Full Text] [Related]
54. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.
Ghesquières H; Berger F; Felman P; Callet-Bauchu E; Bryon PA; Traverse-Glehen A; Thieblemont C; Baseggio L; Michallet AS; Coiffier B; Salles G
J Clin Oncol; 2006 Nov; 24(33):5234-41. PubMed ID: 17043351
[TBL] [Abstract][Full Text] [Related]
55. Intestinal and Extraintestinal Cancers Associated With Inflammatory Bowel Disease.
Chang M; Chang L; Chang HM; Chang F
Clin Colorectal Cancer; 2018 Mar; 17(1):e29-e37. PubMed ID: 28712945
[TBL] [Abstract][Full Text] [Related]
56. Splenic lymphoproliferative disorders in human T lymphotropic virus type-I endemic area of japan: clinicopathological, immunohistochemical and genetic analysis of 27 cases.
Kumagawa M; Suzumiya J; Ohshima K; Kanda M; Tamura K; Kikuchi M
Leuk Lymphoma; 2001 May; 41(5-6):593-605. PubMed ID: 11378577
[TBL] [Abstract][Full Text] [Related]
57. The prevalence of Epstein-Barr virus infection in head and neck non-Hodgkin's lymphomas in Khorasan, northeast of Iran.
Abadi RZ; Sistani NS; Mohtasham N; Hesari KK; Vaezi T; Pazouki M; Shakeri MT
J Pak Med Assoc; 2013 Jul; 63(7):882-7. PubMed ID: 23901714
[TBL] [Abstract][Full Text] [Related]
58. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
[TBL] [Abstract][Full Text] [Related]
59. Host ethnicity influences non-Hodgkin's lymphoma subtype frequency and Epstein-Barr virus association rate: the experience of a multi-ethnic patient population in Malaysia.
Peh SC
Histopathology; 2001 May; 38(5):458-65. PubMed ID: 11422484
[TBL] [Abstract][Full Text] [Related]
60. Does IBD Portend Worse Outcomes in Patients with Rectal Cancer? A Case-Matched Analysis.
Alsughayer A; Grass F; McKenna NP; Petersen M; Mathis KL; Lightner AL
Dis Colon Rectum; 2020 Sep; 63(9):1265-1275. PubMed ID: 33216497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
